Breed's Hill Capital’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
Other funds holding LLY
Breed's Hill Capital's LLY Position: Q2 2025 in Review
Breed's Hill Capital increased its Eli Lilly (LLY) stake by 6.4% in Q2 2025, buying an estimated $69.2K and bringing the position to 1,484 shares worth $1.16M. The position accounts for 0.56% of the portfolio, ranked #30.
Breed's Hill Capital first reported a position in LLY in Q4 2023 and has held it in 7 quarters since. 3,914 funds tracked by Wall St. Rank hold LLY as of Q2 2025.
- Breed's Hill Capital held 1,484 shares of Eli Lilly worth $1.16M as of Q2 2025.
- Breed's Hill Capital bought 89 Eli Lilly shares in Q2 2025, an estimated $69.2K.
- Eli Lilly made up 0.56% of Breed's Hill Capital's portfolio in Q2 2025, its #30 holding.
- Breed's Hill Capital first reported a position in Eli Lilly in Q4 2023 and has held it in 7 quarters since.
- 3,914 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2025.
Based on Breed's Hill Capital's 13F filing for Q2 2025, filed 8 Aug 2025.